Acuta Capital Partners’s Sage Therapeutics SAGE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q3 | – | Sell |
-50,945
| Closed | -$2.89M | – | 52 |
|
|
2021
Q2 | $2.89M | Sell |
50,945
-67,555
| -57% | -$3.84M | 1.16% | 29 |
|
|
2021
Q1 | $8.87M | Sell |
118,500
-137,300
| -54% | -$10.3M | 3.2% | 8 |
|
|
2020
Q4 | $22.1M | Buy |
255,800
+30,800
| +14% | +$2.66M | 6.02% | 2 |
|
|
2020
Q3 | $13.8M | Buy |
+225,000
| New | +$13.8M | 3.73% | 4 |
|
|
2017
Q2 | – | Hold |
0
| – | – | – | 53 |
|
|
2017
Q1 | – | Hold |
0
| – | – | – | 54 |
|
|
2016
Q1 | – | Sell |
-16,877
| Closed | -$984K | – | 46 |
|
|
2015
Q4 | $984K | Buy |
+16,877
| New | +$984K | 0.47% | 37 |
|
|
2015
Q2 | – | Sell |
-8,000
| Closed | -$402K | – | 58 |
|
|
2015
Q1 | $402K | Buy |
+8,000
| New | +$402K | 0.34% | 42 |
|